Go ahead for new treatment for Black Bone Disease
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
LJMU have secured prestigious funding to develop novel approaches to sustainable mining in the Philippines.
Liverpool John Moores University is set to train more people in diagnosing cancer thanks to a partnership with global optics firm Olympus.
Amid relief and joy, almost 100 of our own university colleagues collected their degrees this week. We spoke to a handful of them ...
Liverpool John Moores University has been chosen as the Consortium Secretariat of a new Going Global Partnership, funded by the British Council, with Malaysia. The new collaboration aims to promote strategic engagement and bilateral cooperation in higher education between partner institutions in both countries.
Simulations of Space aid public and scientific understanding of science
As part of the University’s commitment to supporting equality and diversity in the forthcoming Research Excellence Framework (REF 2021), we have put in place safe and supportive structures for eligible academic staff to declare information about any equality-related circumstances that may have affected their ability to research productively during the assessment period (1 January 2014 – 31 December 2020), and particularly their ability to produce research outputs at the same rate as staff not affected by circumstances.
LJMU has collaborated with LCR to transfer £132,000 of unspent Apprenticeship Levy to Autism Initiatives, funding 44 new apprentice care workers for the charity.
As part of the University's commitment to supporting equality and diversity in the forthcoming Research Excellence Framework (REF 2021), we have put in place safe and supportive structures for eligible academic staff to declare information about any equality-related circumstances that may have affected their ability to research productively during the assessment period (1 January 2014 - 31 December 2020), and particularly their ability to produce research outputs at the same rate as staff not affected by circumstances.
As part of the Universitys commitment to supporting equality and diversity in the forthcoming Research Excellence Framework (REF 2021), we have put in place safe and supportive structures for eligible academic staff to declare information about any equality-related circumstances that may have affected their ability to research productively during the assessment period (1 January 2014 31 December 2020).